R3HDM4 Activators
R3HDM4 employ a variety of pathways to modulate its activity. Forskolin, by activating adenylate cyclase, results in the elevation of cAMP levels within the cell, which in turn activates protein kinase A (PKA). PKA is known to phosphorylate a myriad of proteins, and this kinase-mediated phosphorylation can lead to the activation of R3HDM4. Similarly, IBMX, by inhibiting phosphodiesterases, prevents the breakdown of cAMP, thereby sustaining the activation signal for PKA and supporting the activation of R3HDM4. Isoproterenol and Epinephrine, both adrenergic agonists, stimulate adenylate cyclase through different receptors but converge on the same outcome: increased cAMP and subsequent PKA activation, providing a conducive environment for R3HDM4 activation. Analogously, 8-Br-cAMP and Dibutyryl cAMP, both synthetic analogs of cAMP, directly activate PKA, bypassing the need for upstream receptor-ligand interactions and streamlining the activation process for R3HDM4.
cAMP-dependent pathways, other signaling molecules contribute to the regulation of R3HDM4. PMA, an activator of protein kinase C (PKC), initiates a phosphorylation cascade that can culminate in the activation of R3HDM4. Ionomycin and A23187, both calcium ionophores, increase intracellular calcium levels, which can activate a range of calcium-dependent kinases capable of modifying R3HDM4 activity. Sphingosine-1-phosphate, through its receptor-mediated activation, can trigger signaling pathways involving kinases that may lead to the phosphorylation and activation of R3HDM4. Anisomycin, although primarily known as a protein synthesis inhibitor, activates stress-activated protein kinases, such as JNK, which can phosphorylate R3HDM4, indicating a role in stress response signaling pathways. Lastly, LY294002, by inhibiting phosphoinositide 3-kinases, may alter signaling cascades and result in the activation of R3HDM4 through indirect regulatory mechanisms within the PI3K/Akt pathway. Each of these chemicals, through its unique mode of action, contributes to the intricate regulation of R3HDM4 activity within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, which increases cAMP by preventing its degradation, thereby supporting PKA activity and potentially enhancing R3HDM4 activation in pathways where PKA-mediated phosphorylation is relevant. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which could lead to the phosphorylation and activation of downstream effectors that interact with and activate R3HDM4. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which could activate calcium-dependent protein kinases and phosphatases, thereby influencing the phosphorylation state and activation of R3HDM4. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with adrenergic receptors leading to the activation of adenylate cyclase and the increase of cAMP, which in turn can activate PKA and potentially lead to the phosphorylation and activation of R3HDM4 through PKA signaling cascades. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, increases intracellular cAMP levels, which activates PKA and could lead to the phosphorylation and subsequent activation of R3HDM4 within the PKA-regulated pathways. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Bromoadenosine 3',5'-cyclic monophosphate is a cell-permeable cAMP analog that activates cAMP-dependent pathways, including PKA, which could lead to the activation of R3HDM4 by mimicking the action of endogenous cAMP. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcimycin (A23187) is a calcium ionophore that raises intracellular calcium concentrations, potentially activating calcium/calmodulin-dependent kinases, which could subsequently activate R3HDM4 through phosphorylation mechanisms. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP is a membrane-permeable analog of cAMP that activates cAMP-dependent PKA, which may lead to the activation of R3HDM4 through phosphorylation by PKA. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases, such as JNK, which might phosphorylate and activate R3HDM4 as part of a stress response signaling pathway. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is a bioactive lipid that activates sphingosine-1-phosphate receptors, leading to downstream signaling events that include activation of kinases which could phosphorylate and activate R3HDM4. | ||||||